Journal of Circulating Biomarkers' Editor-in-Chief and EB members to speak at Selectbio's "Biofluid Biopsies & High-Value Diagnostics 2015" Conference
July 13, 2015
We are pleased to inform you that the Journal of Circulating Biomarkers will be presented by one of its Editors-in-Chief, Dr. Winston Patrick Kuo (Harvard Medical School, USA), at the "Biofluid Biopsies & High-Value Diagnostics 2015" conference. The event will take place on November 16-17, 2015, in Boston (USA).
In addition to the journal’s Editor-in-Chief, the following Associate Editors and Editorial Board Member will also be be speaking at the conference:
- David T. Wong, Associate Editor, University of California Los Angeles (USA)
- Johan Skog, Associate Editor, Exosome Diagnostics (USA)
- Dolores Di Vizio, Editorial Board Member, Harvard Medical School (USA)
The 2nd annual "Biofluid Biopsies & High Value Diagnostics 2015" conference brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes. The Biofluid Biopsies Conference Track focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers, while the High-Value Diagnostics Conference Track explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for patient monitoring and precision/targeted medicine.
We invite all interested parties to register for the event here.
For more information regarding the conference, its program, call for posters, sponsorship and exhibition opportunities, please click here.